Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2023-06, Vol.41 (S2), p.381-382 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 382 |
|---|---|
| container_issue | S2 |
| container_start_page | 381 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Ujjani, C. Wang, H. Broome, C. Gopal, A. Lai, C. Warren, E. Shadman, M. Smith, S. D. Lynch, R. Swanson, N. Grossfeld, T. Sorensen, T. Cheson, B. D. Dunleavy, K. |
| description | |
| doi_str_mv | 10.1002/hon.3164_276 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089983745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089983745</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1494-f3c1b77cda9fc0058d3e76fe796c9987fceba2bcb1facbfa261a38332bda8a8c3</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoOKd3_oCCt3bmo2uSSxnuA4aDod6GkzRhHV1Tkxbtv1_n9Narl8P78B54ELoneEIwpk87X08YyTNFeX6BRgRLmRKcy0s0wpSLFFNGr9FNjHuMhw6LEVqsdOjasi51AnWRfNjatt5U8J2UdbK1FTTRFj_V1roApvWhT-a-qkrTVRCSdX9odv4At-jKQRXt3W-O0fv85W22TNebxWr2vE4NyWSWOmaI5twUIJ3BeCoKZnnuLJe5kVJwZ6wGqo0mDox2QHMCTDBGdQEChGFj9HDebYL_7Gxs1d53oR5eKobFMMF4Nh2oxzNlgo8xWKeaUB4g9IpgdVKlBlXqT9WAT8_4V1nZ_l9WLTevpzjd7AjYcm35</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089983745</pqid></control><display><type>article</type><title>Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma</title><source>Access via Wiley Online Library</source><creator>Ujjani, C. ; Wang, H. ; Broome, C. ; Gopal, A. ; Lai, C. ; Warren, E. ; Shadman, M. ; Smith, S. D. ; Lynch, R. ; Swanson, N. ; Grossfeld, T. ; Sorensen, T. ; Cheson, B. D. ; Dunleavy, K.</creator><creatorcontrib>Ujjani, C. ; Wang, H. ; Broome, C. ; Gopal, A. ; Lai, C. ; Warren, E. ; Shadman, M. ; Smith, S. D. ; Lynch, R. ; Swanson, N. ; Grossfeld, T. ; Sorensen, T. ; Cheson, B. D. ; Dunleavy, K.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3164_276</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.381-382</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.3164_276$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.3164_276$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids></links><search><creatorcontrib>Ujjani, C.</creatorcontrib><creatorcontrib>Wang, H.</creatorcontrib><creatorcontrib>Broome, C.</creatorcontrib><creatorcontrib>Gopal, A.</creatorcontrib><creatorcontrib>Lai, C.</creatorcontrib><creatorcontrib>Warren, E.</creatorcontrib><creatorcontrib>Shadman, M.</creatorcontrib><creatorcontrib>Smith, S. D.</creatorcontrib><creatorcontrib>Lynch, R.</creatorcontrib><creatorcontrib>Swanson, N.</creatorcontrib><creatorcontrib>Grossfeld, T.</creatorcontrib><creatorcontrib>Sorensen, T.</creatorcontrib><creatorcontrib>Cheson, B. D.</creatorcontrib><creatorcontrib>Dunleavy, K.</creatorcontrib><title>Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma</title><title>Hematological oncology</title><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMoOKd3_oCCt3bmo2uSSxnuA4aDod6GkzRhHV1Tkxbtv1_n9Narl8P78B54ELoneEIwpk87X08YyTNFeX6BRgRLmRKcy0s0wpSLFFNGr9FNjHuMhw6LEVqsdOjasi51AnWRfNjatt5U8J2UdbK1FTTRFj_V1roApvWhT-a-qkrTVRCSdX9odv4At-jKQRXt3W-O0fv85W22TNebxWr2vE4NyWSWOmaI5twUIJ3BeCoKZnnuLJe5kVJwZ6wGqo0mDox2QHMCTDBGdQEChGFj9HDebYL_7Gxs1d53oR5eKobFMMF4Nh2oxzNlgo8xWKeaUB4g9IpgdVKlBlXqT9WAT8_4V1nZ_l9WLTevpzjd7AjYcm35</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Ujjani, C.</creator><creator>Wang, H.</creator><creator>Broome, C.</creator><creator>Gopal, A.</creator><creator>Lai, C.</creator><creator>Warren, E.</creator><creator>Shadman, M.</creator><creator>Smith, S. D.</creator><creator>Lynch, R.</creator><creator>Swanson, N.</creator><creator>Grossfeld, T.</creator><creator>Sorensen, T.</creator><creator>Cheson, B. D.</creator><creator>Dunleavy, K.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma</title><author>Ujjani, C. ; Wang, H. ; Broome, C. ; Gopal, A. ; Lai, C. ; Warren, E. ; Shadman, M. ; Smith, S. D. ; Lynch, R. ; Swanson, N. ; Grossfeld, T. ; Sorensen, T. ; Cheson, B. D. ; Dunleavy, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1494-f3c1b77cda9fc0058d3e76fe796c9987fceba2bcb1facbfa261a38332bda8a8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ujjani, C.</creatorcontrib><creatorcontrib>Wang, H.</creatorcontrib><creatorcontrib>Broome, C.</creatorcontrib><creatorcontrib>Gopal, A.</creatorcontrib><creatorcontrib>Lai, C.</creatorcontrib><creatorcontrib>Warren, E.</creatorcontrib><creatorcontrib>Shadman, M.</creatorcontrib><creatorcontrib>Smith, S. D.</creatorcontrib><creatorcontrib>Lynch, R.</creatorcontrib><creatorcontrib>Swanson, N.</creatorcontrib><creatorcontrib>Grossfeld, T.</creatorcontrib><creatorcontrib>Sorensen, T.</creatorcontrib><creatorcontrib>Cheson, B. D.</creatorcontrib><creatorcontrib>Dunleavy, K.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ujjani, C.</au><au>Wang, H.</au><au>Broome, C.</au><au>Gopal, A.</au><au>Lai, C.</au><au>Warren, E.</au><au>Shadman, M.</au><au>Smith, S. D.</au><au>Lynch, R.</au><au>Swanson, N.</au><au>Grossfeld, T.</au><au>Sorensen, T.</au><au>Cheson, B. D.</au><au>Dunleavy, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>381</spage><epage>382</epage><pages>381-382</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3164_276</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.381-382 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089983745 |
| source | Access via Wiley Online Library |
| subjects | Lymphoma |
| title | Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T21%3A45%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ibrutinib%20and%20Venetoclax%20in%20Relapsed%20and%20Refractory%20Follicular%20Lymphoma&rft.jtitle=Hematological%20oncology&rft.au=Ujjani,%20C.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=381&rft.epage=382&rft.pages=381-382&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3164_276&rft_dat=%3Cproquest_cross%3E3089983745%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089983745&rft_id=info:pmid/&rfr_iscdi=true |